This announcement is for informational purposes only and does not
constitute an offer to purchase or a solicitation of an offer to sell
HGS common stock. The solicitation and offer to buy HGS common stock,
commenced by GlaxoSmithKline plc through its wholly owned subsidiary, H.
Acquisition Corp., have been made pursuant to an offer to purchase and
related materials, filed on Schedule TO with the U.S. Securities and
Exchange Commission (SEC), as amended and as will be further amended
from time to time. In response to the offer, HGS has filed a
solicitation/recommendation statement on Schedule 14D-9 with the SEC, as
amended and as will be further amended from time to time. Investors and
securityholders are urged to read these materials carefully since they
contain important information, including the terms and conditions of the
offer. Investors and security holders may obtain free copies of these
materials and other documents filed by GSK and HGS with the SEC at the
website maintained by the SEC as
The offer to purchase and related materials may also be obtained for
free by contacting the information agent for the tender offer, D.F. King
& Co., Inc. at (212) 269-5550 or (800) 848-2998 (toll-free) or by email
will also provide a copy of the solicitation/recommendation statement
materials without charge on its website at
or HGS stockholders may call HGS’ Information Agent, Innisfree M&A
Incorporated, toll-free at 877-717-3926.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV